Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 205

    1.

    Accuracy of screening for inhalational anthrax after a bioterrorist attack.

    Hupert N, Bearman GM, Mushlin AI, Callahan MA.

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):337-45.PMID: 12965942 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Screening for inhalational anthrax after a bioterrorist attack.

    [No authors listed]

    Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I49. No abstract available. PMID: 12965957 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical predictors of bioterrorism-related inhalational anthrax.

    Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerichs RR.

    Lancet. 2004 Jul 31-Aug 6;364(9432):449-52.PMID: 15288744 [PubMed - indexed for MEDLINE]Related articles

    4.

    The primary care differential diagnosis of inhalational anthrax.

    Temte JL, Zinkel AR.

    Ann Fam Med. 2004 Sep-Oct;2(5):438-44.PMID: 15506578 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Anthrax: a systematic review of atypical presentations.

    Holty JE, Kim RY, Bravata DM.

    Ann Emerg Med. 2006 Aug;48(2):200-11. Epub 2006 Feb 21. Review.PMID: 16857469 [PubMed - indexed for MEDLINE]Related articles

    6.

    Death due to bioterrorism-related inhalational anthrax: report of 2 patients.

    Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, Ripple M, Ali S, DiAngelo C, Lee J, Arden J, Titus J, Fowler D, O'Toole T, Masur H, Bartlett J, Inglesby T.

    JAMA. 2001 Nov 28;286(20):2554-9.PMID: 11722269 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.

    Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, Pauze D, Nguyen M, Rosenthal J, Cerva D Jr, Druckenbrod G, Hanfling D, Fatteh N, Napoli A, Nayyar A, Berman EL.

    JAMA. 2001 Nov 28;286(20):2549-53.PMID: 11722268 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pediatric anthrax: implications for bioterrorism preparedness.

    Bravata DM, Wang E, Holty JE, Lewis R, Wise PH, Nayak S, Liu H, McDonald KM, Owens DK.

    Evid Rep Technol Assess (Full Rep). 2006 Aug;(141):1-48. Review.PMID: 17764208 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Bioterrorism-related inhalational anthrax: can extrapolated adult guidelines be applied to a pediatric population?

    Place RC, Hanfling D, Howell JM, Mayer TA.

    Biosecur Bioterror. 2007 Mar;5(1):35-42.PMID: 17437350 [PubMed - indexed for MEDLINE]Related articles

    10.

    When bioterrorism strikes: diagnosis and management of inhalational anthrax.

    Shafazand S.

    Semin Respir Infect. 2003 Sep;18(3):134-45. Review.PMID: 14505276 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.

    Quintiliani R Jr, Quintiliani R.

    Conn Med. 2002 May;66(5):261-7.PMID: 12071107 [PubMed - indexed for MEDLINE]Related articles

    12.

    Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols.

    Howell JM, Mayer TA, Hanfling D, Morrison A, Druckenbrod G, Murphy C, Cates R, Pauze D.

    Clin Infect Dis. 2004 Dec 15;39(12):1842-7. Epub 2004 Nov 18.PMID: 15578409 [PubMed - indexed for MEDLINE]Related articles

    14.

    Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective.

    Patt HA, Feigin RD.

    Pediatrics. 2002 Apr;109(4):685-92. Review.PMID: 11927716 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [Anthrax--an overview at 2002]

    Mozes YN, Winder A, Tadmor B, Rotman E, Sagi R, Hourvitz A.

    Harefuah. 2002 May;141 Spec No:63-72, 121, 120. Review. Hebrew. PMID: 12170557 [PubMed - indexed for MEDLINE]Related articles

    16.

    No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.

    Baggett HC, Rhodes JC, Fridkin SK, Quinn CP, Hageman JC, Friedman CR, Dykewicz CA, Semenova VA, Romero-Steiner S, Elie CM, Jernigan JA.

    Clin Infect Dis. 2005 Oct 1;41(7):991-7. Epub 2005 Aug 29.PMID: 16142664 [PubMed - indexed for MEDLINE]Related articles

    17.

    Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2001 Nov 30;50(47):1049-51.PMID: 11808925 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?

    Mayer TA, Morrison A, Bersoff-Matcha S, Druckenbrod G, Murphy C, Howell J, Hanfling D, Cates R, Pauze D, Earls J.

    Clin Infect Dis. 2003 May 15;36(10):1275-83. Epub 2003 May 9.PMID: 12746773 [PubMed - indexed for MEDLINE]Related articles

    19.

    Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm.

    Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL.

    Chest. 2007 Feb;131(2):489-96.PMID: 17296652 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Considerations for distinguishing influenza-like illness from inhalational anthrax.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2001 Nov 9;50(44):984-6.PMID: 11724153 [PubMed - indexed for MEDLINE]Related articlesFree article